Pak activist Asma Jahangir honoured with top UN human rights award

Agencies
December 20, 2018

United Nations, Dec 20: Pakistan's renowned social activist Asma Jahangir was posthumously honoured by the UN with a prestigious human rights award.

Jahangir, an outspoken critic of Pakistan's powerful military establishment, fought against religious extremism and for the rights of oppressed minorities in Pakistan. She died of cardiac arrest at the age of 66 in February.

She was honoured with the 2018 United Nations Human Rights Prize, an award given every five years since 1968.

Jahangir's daughter Munizae Jahangir received the award on her behalf from President of the UN General Assembly María Fernanda Espinosa at a special ceremony here Tuesday.

Among others who won the award include girls' education rights activist Rebeca Gyumi of Tanzania, Brazil's first indigenous woman lawyer Joenia Batista de Carvalho and Front Line Defenders from Ireland, working to protect human rights defenders at risk.

UN Secretary General Antonio Guterres said that the work of the honourees and that of other human rights defenders around the world is essential for the collective efforts to sustain peace and ensure inclusive sustainable development and respect for human rights for all.

"Often their work is dangerous. We regularly hear of abuses against human rights defenders — murder, disappearances, torture, arbitrary imprisonment and other attempts to silence them.

"Yet, these courageous individuals and groups remain committed to shining a light on the dark corners of the globe, wherever human rights violations occur," he said in his remarks to the General Assembly's United Nations Prize in the Field of Human Rights award ceremony.

The event commemorated the 70th Anniversary of the Universal Declaration of Human Rights, marked annually on December 10.

Guterres said human rights defenders give voice to the voiceless and shield the powerless against injustice.

"They stand for all rights — economic, civil, political, social and cultural. They support the rule of law or work peacefully to change laws so women and girls, indigenous communities, minorities and other marginalised groups may exercise their rights," he said.

Guterres said they they work to empower people through education, and help to protect other human rights defenders from harassment, intimidation or arrest.

As part of the UN's activities in observance of Human Rights Day, which coincided with the Declaration's anniversary, the champions in the field from across the world, convened at the General Assembly Hall to be recognised for their outstanding contributions.

Every five years, the United Nations Prize in the Field of Human Rights is awarded to organisations and individuals which embody excellent activism in defending human rights.

The four winners join a notable group who have been recognised since the Prize was established by the General Assembly in 1966, including prominent figures such as Eleanor Roosevelt, Martin Luther King, Nelson Mandela, Jimmy Carter, Malala Yusafzai and this year's Nobel Peace Prize winners, Denis Mukwege and Nadia Murad, as well as organisations such as the Amnesty International and the International Committee of the Red Cross.

Marking the 70th anniversary of the Universal Declaration of Human Rights, Espinosa said it was one of the most important contributions that the world body has made to mankind, reflecting the collective aspirations of an international order founded on human dignity and with a view to making the world a better place.

UN High Commissioner for Human Rights Michelle Bachelet said upholding all people's human rights is the only possible path to peace.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 28,2020

Washington, Mar 27: The United States has seen a record 18,000 new confirmed coronavirus cases and 345 deaths over the past 24 hours, according to a Johns Hopkins University tracker.

There are now 97,028 declared virus cases in the country and there have been 1,475 deaths, Johns Hopkins said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 16,2020

Islamabad, Apr 16: The number of coronavirus cases in Pakistan topped 6000 while the death toll due to the virus has reached 117, Dawn reported citing official data on Wednesday.

Over 1,446 people have recovered in the country from the deadly virus that has killed over 1.3 lakh people worldwide.

The total number of cases in the country has reached 6297 with Punjab being the worst affected province with 3,016 cases. Meanwhile, Sindh has 1,688 cases of the deadly virus.

Khyber Pakhtunkhwa has reported 47 new cases of the coronavirus, taking the provincial total to 912. Most of the new cases are of Tableeghi Jamaat members who have travel history.

Balochistan has reported four new cases of COVID-19, taking the provincial total to 281 according to provincial government spokesperson Liaquat Shahwani.

On Tuesday, Prime Minister Imran Khan had announced the extension of the nationwide lockdown with relaxation to some sectors.

Addressing the media in Islamabad on Tuesday, Khan said, "We made the hard decision of imposing lockdown in the country which was very well implemented due to cooperation of the people."

The countrywide lockdown was imposed last month in a bid to stem the spread of coronavirus. Later, a two-week extension was announced in the restrictions until April 14.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.